Trial Profile
A phase 1 clinical study of SAR441236 in healthy subjects
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 23 Oct 2018
Price :
$35
*
At a glance
- Drugs SAR 441236 (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacodynamics
- 23 Oct 2018 New trial record